CONMED Corporation
CNMD · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2 | $3 | $3 | $4 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $3 | $4 | $4 | $5 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 5% | 19.1% | 3.4% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 56.1% | 54.3% | 54.6% | 56.2% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 20.8% | 15.5% | 0.7% | 17.7% |
| Net Income | $0 | $0 | -$0 | $0 |
| % Margin | 10.1% | 5.2% | -7.7% | 6.2% |
| EPS Diluted | 4.26 | 2.04 | -2.68 | 1.94 |
| % Growth | 108.8% | 176.1% | -238.1% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |